ING Group’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
Sell
-1,600
Closed -$16.3K 654
2023
Q3
$16.3K Hold
1,600
﹤0.01% 582
2023
Q2
$12K Hold
1,600
﹤0.01% 521
2023
Q1
$14.2K Buy
+1,600
New +$14.2K ﹤0.01% 615
2019
Q3
Sell
-46,470
Closed -$429K 723
2019
Q2
$429K Buy
46,470
+23,500
+102% +$217K 0.01% 561
2019
Q1
$360K Buy
22,970
+4,000
+21% +$62.7K 0.01% 551
2018
Q4
$293K Sell
18,970
-4,500
-19% -$69.5K 0.01% 591
2018
Q3
$506K Buy
23,470
+6,890
+42% +$149K 0.01% 507
2018
Q2
$403K Buy
16,580
+6,000
+57% +$146K 0.01% 525
2018
Q1
$181K Sell
10,580
-11,300
-52% -$193K ﹤0.01% 693
2017
Q4
$415K Sell
21,880
-3,150
-13% -$59.7K 0.01% 552
2017
Q3
$441K Sell
25,030
-25,990
-51% -$458K 0.01% 537
2017
Q2
$1.7M Sell
51,020
-2,000
-4% -$66.4K 0.03% 240
2017
Q1
$1.7M Buy
+53,020
New +$1.7M 0.03% 273
2016
Q4
Sell
-6,030
Closed -$279K 604
2016
Q3
$279K Buy
6,030
+480
+9% +$22.2K ﹤0.01% 511
2016
Q2
$279K Hold
5,550
﹤0.01% 447
2016
Q1
$297K Hold
5,550
﹤0.01% 453
2015
Q4
$364K Hold
5,550
﹤0.01% 591
2015
Q3
$313K Hold
5,550
﹤0.01% 530
2015
Q2
$328K Sell
5,550
-10,000
-64% -$591K ﹤0.01% 588
2015
Q1
$969K Hold
15,550
﹤0.01% 598
2014
Q4
$894K Sell
15,550
-12,000
-44% -$690K ﹤0.01% 592
2014
Q3
$1.48M Hold
27,550
0.01% 493
2014
Q2
$1.44M Sell
27,550
-54,214
-66% -$2.84M 0.01% 494
2014
Q1
$4.32M Buy
81,764
+65,532
+404% +$3.46M 0.02% 390
2013
Q4
$651K Sell
16,232
-10,581
-39% -$424K ﹤0.01% 590
2013
Q3
$1.01M Buy
26,813
+9,788
+57% +$370K 0.01% 565
2013
Q2
$667K Buy
+17,025
New +$667K ﹤0.01% 582